Transcriptome sequencing implicates dorsal striatum-specific gene network, immune response and energy metabolism pathways in bipolar disorder

Molecular Psychiatry

Volumn 22, Issue 3, 2017, Pages 441-449

  Pacifico, R ^a   Davis, R L ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN C; TRANSCRIPTOME;

ADOLESCENT; ADULT; AGED; ARTICLE; BIPOLAR DISORDER; CHILD; CONTROLLED STUDY; DORSAL STRIATUM; DOWN REGULATION; ENERGY METABOLISM; FCGBP GENE; FEMALE; GENE; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENOME-WIDE ASSOCIATION STUDY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; INFANT; INFLAMMATION; LILRA4 GENE; MALE; NLRC5 GENE; OXIDATIVE PHOSPHORYLATION; PATHOGENESIS; RNA SEQUENCE; S100A12 GENE; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION; ACTIVE IMMUNIZATION; AUTOPSY; BRAIN; CENTRAL NERVOUS SYSTEM; CORPUS STRIATUM; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORK; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MIDDLE AGED; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AUTOPSY; BIPOLAR DISORDER; BRAIN; CENTRAL NERVOUS SYSTEM; CORPUS STRIATUM; ENERGY METABOLISM; FEMALE; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; IMMUNITY, ACTIVE; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSCRIPTOME;

EID: 84976318124     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2016.94     Document Type: Article

References (69)

1. Merikangas KR, Jin R, He JP, Kessler RC, Lee S, Sampson NA et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry 2011; 68: 241-251.
2. Moeller FG, Barratt ES, Dougherty DM, Schmitz JM, Swann AC. Psychiatric aspects of impulsivity. Am J Psychiatry 2001; 158: 1783-1793.
3. Strakowski SM, Fleck DE, DelBello MP, Adler CM, Shear PK, McElroy SL et al. Characterizing impulsivity in mania. Bipolar Disord 2009; 11: 41-51.
4. Alloy LB, Nusslock R, Boland EM. The development and course of bipolar spectrum disorders: an integrated reward and circadian rhythm dysregulation model. Ann Rev Clin Psychol 2015; 11: 213-250.
5. Balleine BW, Delgado MR, Hikosaka O. The role of the dorsal striatum in reward and decision-making. J Neurosci 2007; 27: 8161-8165.
6. Yanike M, Ferrera VP. Representation of outcome risk and action in the anterior caudate nucleus. J Neurosci 2014; 34: 3279-3290.
7. Aylward EH, Roberts-Twillie JV, Barta PE, Kumar AJ, Harris GJ, Geer M et al. Basal ganglia volumes and white matter hyperintensities in patients with bipolar disorder. Am J Psychiatry 1994; 151: 687-693.
8. Strakowski SM, DelBello MP, Sax KW, Zimmerman ME, Shear PK, Hawkins JM et al. Brain magnetic resonance imaging of structural abnormalities in bipolar disorder. Arch Gen Psychiatry 1999; 56: 254-260.
9. Blumberg HP, Martin A, Kaufman J, Leung HC, Skudlarski P, Lacadie C et al. Frontostriatal abnormalities in adolescents with bipolar disorder: preliminary observations from functional MRI. Am J Psychiatry 2003; 160: 1345-1347.
10. O'Connell RA, Van Heertum RL, Luck D, Yudd AP, Cueva JE, Billick SB et al. Single-photon emission computed tomography of the brain in acute mania and schizophrenia. J Neuroimaging 1995; 5: 101-104.
11. Wessa M, Houenou J, Paillere-Martinot ML, Berthoz S, Artiges E, Leboyer M et al. Fronto-striatal overactivation in euthymic bipolar patients during an emotional go/nogo task. Am J Psychiatry 2007; 164: 638-646.
12. Anand A, Barkay G, Dzemidzic M, Albrecht D, Karne H, Zheng QH et al. Striatal dopamine transporter availability in unmedicated bipolar disorder. Bipolar Disord 2011; 13: 406-413.
13. Bertelsen A, Harvald B, Hauge M. A Danish twin study of manic-depressive disorders. Br J Psychiatry 1977; 130: 330-351.
14. Lichtenstein P, Yip BH, Bjork C, Pawitan Y, Cannon TD, Sullivan PF et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 2009; 373: 234-239.
15. McGuffin P, Rijsdijk F, Andrew M, Sham P, Katz R, Cardno A. The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Arch Gen Psychiatry 2003; 60: 497-502.
16. Baum AE, Akula N, Cabanero M, Cardona I, Corona W, Klemens B et al. A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Mol Psychiatry 2008; 13: 197-207.
17. Cross-Disorder Group of the Psychiatric Genomics C, Lee SH, Ripke S, Neale BM, Faraone SV, Purcell SM et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet 2013; 45: 984-994.
18. Lee SH, Wray NR, Goddard ME, Visscher PM. Estimating missing heritability for disease from genome-wide association studies. Am J Hum Genet 2011; 88: 294-305.
19. Psychiatric GCBDWG. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet 2011; 43: 977-983.
20. Akula N, Barb J, Jiang X, Wendland JR, Choi KH, Sen SK et al. RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms and GTPase binding in bipolar disorder. Mol Psychiatry 2014; 19: 1179-1185.
21. Seifuddin F, Pirooznia M, Judy JT, Goes FS, Potash JB, Zandi PP. Systematic review of genome-wide gene expression studies of bipolar disorder. BMC Psychiatry 2013; 13: 213.
22. Zhao Z, Xu J, Chen J, Kim S, Reimers M, Bacanu SA et al. Transcriptome sequencing and genome-wide association analyses reveal lysosomal function and actin cytoskeleton remodeling in schizophrenia and bipolar disorder. Mol Psychiatry 2014.
23. Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods 2012; 9: 357-359.
24. Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol 2013; 14: R36.
25. Anders S, Pyl PT, Huber W. HTSeq-a Python framework to work with high-throughput sequencing data. Bioinformatics 2015; 31: 166-169.
26. Wang L, Wang S, Li W. RSeQC: quality control of RNA-seq experiments. Bioinfor-matics 2012; 28: 2184-2185.
27. Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 2014; 15: 550.
28. Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC BIoinformatics 2008; 9: 559.
29. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102: 15545-15550.
30. Xiong Q, Mukherjee S, Furey TS. GSAASeqSP: a toolset for gene set association analysis of RNA-Seq data. Sci Rep 2014; 4: 6347.
31. Eden E, Navon R, Steinfeld I, Lipson D, Yakhini Z. GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists. BMC Bioinformatics 2009; 10: 48.
32. Voineagu I, Wang X, Johnston P, Lowe JK, Tian Y, Horvath S et al. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 2011; 474: 380-384.
33. Wang K, Li M, Bucan M. Pathway-based approaches for analysis of genomewide association studies. Am J Hum Genet 2007; 81: 1278-1283.
34. Wood AR, Esko T, Yang J, Vedantam S, Pers TH, Gustafsson S et al. Defining the role of common variation in the genomic and biological architecture of adult human height. Nat Genet 2014; 46: 1173-1186.
35. Dougherty JD, Schmidt EF, Nakajima M, Heintz N. Analytical approaches to RNA profiling data for the identification of genes enriched in specific cells. Nucleic Acids Res 2010; 38: 4218-4230.
36. Xu X, Wells AB, O'Brien DR, Nehorai A, Dougherty JD. Cell type-specific expression analysis to identify putative cellular mechanisms for neurogenetic disorders. J Neurosci 2014; 34: 1420-1431.
37. Zhao W, He X, Hoadley KA, Parker JS, Hayes DN, Perou CM. Comparison of RNA-Seq by poly (A) capture, ribosomal RNA depletion, and DNA microarray for expression profiling. BMC Genomics 2014; 15: 419.
38. Cui P, Lin Q, Ding F, Xin C, Gong W, Zhang L et al. A comparison between ribo-minus RNA-sequencing and polyA-selected RNA-sequencing. Genomics 2010; 96: 259-265.
39. Sigurgeirsson B, Emanuelsson O, Lundeberg J. Sequencing degraded RNA addressed by 3' tag counting. PloS One 2014; 9: e91851.
40. Bergen SE, O'Dushlaine CT, Ripke S, Lee PH, Ruderfer DM, Akterin S et al. Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder. Mol Psychiatry 2012; 17: 880-886.
41. Meissner TB, Li A, Biswas A, Lee KH, Liu YJ, Bayir E et al. NLR family member NLRC5 is a transcriptional regulator of MHC class I genes. Proc Natl Acad Sci USA 2010; 107: 13794-13799.
42. Iavarone F, Melis M, Platania G, Cabras T, Manconi B, Petruzzelli R et al. Characterization of salivary proteins of schizophrenic and bipolar disorder patients by top-down proteomics. J Proteomics 2014; 103: 15-22.
43. Kim JY, So KJ, Lee S, Park JH. Bcl-rambo induces apoptosis via interaction with the adenine nucleotide translocator. FEBS Lett 2012; 586: 3142-3149.
44. Lowthert L, Leffert J, Lin A, Umlauf S, Maloney K, Muralidharan A et al. Increased ratio of anti-apoptotic to pro-apoptotic Bcl2 gene-family members in lithium-responders one month after treatment initiation. Biol Mood Anxiety Disord 2012; 2: 15.
45. Altar CA, Vawter MP, Ginsberg SD. Target identification for CNS diseases by transcriptional profiling. Neuropsychopharmacology 2009; 34: 18-54.
46. Konradi C, Sillivan SE, Clay HB. Mitochondria, oligodendrocytes and inflammation in bipolar disorder: evidence from transcriptome studies points to intriguing parallels with multiple sclerosis. Neurobiol Dis 2012; 45: 37-47.
47. Hakobyan S, Boyajyan A, Sim RB. Classical pathway complement activity in schizophrenia. Neurosci Lett 2005; 374: 35-37.
48. McKernan DP, Dennison U, Gaszner G, Cryan JF, Dinan TG. Enhanced peripheral toll-like receptor responses in psychosis: further evidence of a pro-inflammatory phenotype. Transl Psychiatry 2011; 1: e36.
49. Andreassen OA, Harbo HF, Wang Y, Thompson WK, Schork AJ, Mattingsdal M et al. Genetic pleiotropy between multiple sclerosis and schizophrenia but not bipolar disorder: differential involvement of immune-related gene loci. Mol Psychiatry 2015; 20: 207-214.
50. Network, Pathway Analysis Subgroup of Psychiatric Genomics C. Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways. Nat Neurosci 2015; 18: 199-209.
51. Berk M, Kapczinski F, Andreazza AC, Dean OM, Giorlando F, Maes M et al. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev 2011; 35: 804-817.
52. Mendlewicz J, Kriwin P, Oswald P, Souery D, Alboni S, Brunello N. Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label study. Int Clin Psychopharmacol 2006; 21: 227-231.
53. Nery FG, Monkul ES, Hatch JP, Fonseca M, Zunta-Soares GB, Frey BN et al. Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study. Hum Psychopharmacol 2008; 23: 87-94.
54. Kaalund SS, Newburn EN, Ye T, Tao R, Li C, Deep-Soboslay A et al. Contrasting changes in DRD1 and DRD2 splice variant expression in schizophrenia and affective disorders, and associations with SNPs in postmortem brain. Mol Psychiatry 2014; 19: 1258-1266.
55. Pissadaki EK, Bolam JP. The energy cost of action potential propagation in dopamine neurons: clues to susceptibility in Parkinson's disease. Front Comput Neurosci 2013; 7: 13.
56. Saxena S, Caroni P. Selective neuronal vulnerability in neurodegenerative diseases: from stressor thresholds to degeneration. Neuron 2011; 71: 35-48.
57. Moskvina V, Craddock N, Holmans P, Nikolov I, Pahwa JS, Green E et al. Gene-wide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk. Mol Psychiatry 2009; 14: 252-260.
58. Caporaso GL, Bibb JA, Snyder GL, Valle C, Rakhilin S, Fienberg AA et al. Drugs of abuse modulate the phosphorylation of ARPP-21, a cyclic AMP-regulated phos-phoprotein enriched in the basal ganglia. Neuropharmacology 2000; 39: 1637-1644.
59. Wada A, Kunii Y, Ikemoto K, Yang Q, Hino M, Matsumoto J et al. Increased ratio of calcineurin immunoreactive neurons in the caudate nucleus of patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2012; 37: 8-14.
60. Tardito D, Tiraboschi E, Kasahara J, Racagni G, Popoli M. Reduced CREB phos-phorylation after chronic lithium treatment is associated with down-regulation of CaM kinase IV in rat hippocampus. Int J Neuropsychopharmacol 2007; 10: 491-496.
61. Scott LJ, Muglia P, Kong XQ, Guan W, Flickinger M, Upmanyu R et al. Genome-wide association and meta-analysis of bipolar disorder in individuals of European ancestry. Proc Natl Acad Sci USA 2009; 106: 7501-7506.
62. Tang B, Dean B, Thomas EA. Disease- and age-related changes in histone acet-ylation at gene promoters in psychiatric disorders. Transl Psychiatry 2011; 1: e64.
63. Kerner B, Lambert CG, Muthen BO. Genome-wide association study in bipolar patients stratified by co-morbidity. PloS One 2011; 6: e28477.
64. McDonald ML, MacMullen C, Liu DJ, Leal SM, Davis RL. Genetic association of cyclic AMP signaling genes with bipolar disorder. Transl Psychiatry 2012; 2: e169.
65. Nurnberger JI Jr, Koller DL, Jung J, Edenberg HJ, Foroud T, Guella I et al. Identification of pathways for bipolar disorder: a meta-analysis. JAMA Psychiatry 2014; 71: 657-664.
66. Redlich R, Dohm K, Grotegerd D, Opel N, Zwitserlood P, Heindel W et al. Reward Processing in Unipolar and Bipolar Depression: A Functional MRI Study. Neu-ropsychopharmacology 2015; 40: 2623-2631.
67. Yip SW, Worhunsky PD, Rogers RD, Goodwin GM. Hypoactivation of the ventral and dorsal striatum during reward and loss anticipation in antipsychotic and mood stabilizer-naive bipolar disorder. Neuropsychopharmacology 2015; 40: 658-666.
68. Seo M, Lee E, Averbeck BB. Action selection and action value in frontal-striatal circuits. Neuron 2012; 74: 947-960.
69. Tai LH, Lee AM, Benavidez N, Bonci A, Wilbrecht L. Transient stimulation of distinct subpopulations of striatal neurons mimics changes in action value. Nat Neurosci 2012; 15: 1281-1289.